| Primary |
| Product Used For Unknown Indication |
39.9% |
| Hypertension |
29.7% |
| Drug Use For Unknown Indication |
7.6% |
| Hypertension Arterial |
3.0% |
| Drug Use For Unknown Indication |
2.3% |
| Type 2 Diabetes Mellitus |
2.0% |
| Acute Myocardial Infarction |
1.7% |
| Atrial Fibrillation |
1.7% |
| Intentional Self-injury |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Blood Pressure |
1.3% |
| Essential Hypertension |
1.0% |
| Hepatitis C |
1.0% |
| Ischaemic Heart Disease Prophylaxis |
1.0% |
| Myocardial Infarction |
1.0% |
| Schimke Immunoosseous Dysplasia |
1.0% |
| Hypertension |
0.7% |
| Hypertension Arterial |
0.7% |
| Blood Pressure High |
0.7% |
| Cardiovascular Event Prophylaxis |
0.7% |
|
| Renal Failure Acute |
11.3% |
| Angioedema |
6.5% |
| Lip Swelling |
6.5% |
| Paraesthesia |
6.5% |
| Hypertension |
4.8% |
| Hypertensive Crisis |
4.8% |
| Hypotension |
4.8% |
| Shock |
4.8% |
| Somnolence |
4.8% |
| Swelling Face |
4.8% |
| Swollen Tongue |
4.8% |
| Tachycardia |
4.8% |
| Tongue Oedema |
4.8% |
| Tremor |
4.8% |
| Vomiting |
4.8% |
| Blood Pressure Increased |
3.2% |
| Chest Pain |
3.2% |
| Cough |
3.2% |
| Dermatitis Bullous |
3.2% |
| Glomerular Filtration Rate Decreased |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
58.3% |
| Hypertension |
10.3% |
| Drug Use For Unknown Indication |
6.9% |
| Type 2 Diabetes Mellitus |
4.6% |
| Glomerulonephritis |
4.0% |
| Hypertension Arterial |
2.9% |
| Hypercholesterolaemia |
2.3% |
| Immune Thrombocytopenic Purpura |
1.7% |
| Nephrotic Syndrome |
1.7% |
| Ill-defined Disorder |
1.1% |
| Urinary Tract Infection |
1.1% |
| Atrial Fibrillation |
0.6% |
| Blood Cholesterol Increased |
0.6% |
| Blood Pressure High |
0.6% |
| Coronary Artery Disease |
0.6% |
| Epilepsy |
0.6% |
| Myocardial Ischemia |
0.6% |
| Neuralgia |
0.6% |
| Onychomycosis |
0.6% |
| Prophylaxis |
0.6% |
|
| Angioedema |
11.4% |
| Syncope |
11.4% |
| Vomiting |
8.6% |
| Lung Disorder |
5.7% |
| Pulmonary Artery Stenosis |
5.7% |
| Throat Irritation |
5.7% |
| Transaminases Increased |
5.7% |
| Urosepsis |
5.7% |
| Vision Blurred |
5.7% |
| Weight Decreased |
5.7% |
| Cardiac Arrest |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
| Irritability |
2.9% |
| Mouth Ulceration |
2.9% |
| Myasthenia Gravis |
2.9% |
| Nervousness |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Osteonecrosis |
2.9% |
| Poisoning Deliberate |
2.9% |
| Pulmonary Artery Stenosis Congenital |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.5% |
| Type 2 Diabetes Mellitus |
9.0% |
| Hypertension |
7.8% |
| Hepatitis C |
5.5% |
| Depression |
5.1% |
| B-cell Lymphoma |
3.9% |
| Diabetes Mellitus |
3.9% |
| Osteoporosis |
3.9% |
| Prophylaxis |
3.5% |
| Acute Myocardial Infarction |
3.1% |
| Hypercholesterolaemia |
3.1% |
| Multiple Sclerosis |
2.4% |
| Blood Cholesterol Increased |
2.0% |
| Chronic Lymphocytic Leukaemia |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Plasma Cell Myeloma |
2.0% |
| Breast Cancer |
1.6% |
| Chronic Myeloid Leukaemia |
1.6% |
| Dementia Alzheimer's Type |
1.6% |
| Non-hodgkin's Lymphoma |
1.6% |
|
| Renal Failure Acute |
15.3% |
| Vomiting |
15.3% |
| Rectal Haemorrhage |
7.1% |
| Nausea |
5.1% |
| Renal Impairment |
5.1% |
| Weight Increased |
5.1% |
| Drug Ineffective |
4.1% |
| Pulmonary Embolism |
4.1% |
| Rash |
4.1% |
| Swelling Face |
4.1% |
| Urinary Tract Infection |
4.1% |
| Dyspnoea |
3.1% |
| Loose Tooth |
3.1% |
| Loss Of Consciousness |
3.1% |
| Myocardial Infarction |
3.1% |
| Pulmonary Oedema |
3.1% |
| Syncope |
3.1% |
| Tremor |
3.1% |
| Vertigo |
3.1% |
| Confusional State |
2.0% |
|
